BTK and diffuse large B-cell lymphoma: In ABC DLBCL cells, high degree of cooperativity has been reported for combining Ibrutinib with inhibitors targeting the parallel SYK-PI3K-AKT-mTORC pathway that emanates upstream from BTK [4, 23, 24].